These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20516140)

  • 41. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
    Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
    J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous anesthetics differentially modulate ligand-gated ion channels.
    Flood P; Krasowski MD
    Anesthesiology; 2000 May; 92(5):1418-25. PubMed ID: 10781289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects.
    Zwart R; Vijverberg HP
    Mol Pharmacol; 1997 Nov; 52(5):886-95. PubMed ID: 9351980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rat nicotinic acetylcholine receptor alpha2beta2 channels: comparison of functional properties with alpha4beta2 channels in Xenopus oocytes.
    Khiroug SS; Khiroug L; Yakel JL
    Neuroscience; 2004; 124(4):817-22. PubMed ID: 15026122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
    Briggs CA; Gubbins EJ; Marks MJ; Putman CB; Thimmapaya R; Meyer MD; Surowy CS
    Mol Pharmacol; 2006 Jul; 70(1):227-40. PubMed ID: 16569710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A noncompetitive, sequential mechanism for inhibition of rat alpha4beta2 neuronal nicotinic acetylcholine receptors by carbamate pesticides.
    Smulders CJ; Van Kleef RG; de Groot A; Gotti C; Vijverberg HP
    Toxicol Sci; 2004 Nov; 82(1):219-27. PubMed ID: 15329441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the alpha4beta2 receptor subtype.
    Papke RL; Webster JC; Lippiello PM; Bencherif M; Francis MM
    J Neurochem; 2000 Jul; 75(1):204-16. PubMed ID: 10854263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
    Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
    Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.
    Broad LM; Zwart R; Pearson KH; Lee M; Wallace L; McPhie GI; Emkey R; Hollinshead SP; Dell CP; Baker SR; Sher E
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1108-17. PubMed ID: 16738207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential inhibition of nicotine- and acetylcholine-evoked currents through alpha4beta2 neuronal nicotinic receptors by tobacco cembranoids in Xenopus oocytes.
    Eaton MJ; Ospina CA; Rodríguez AD; Eterović VA
    Neurosci Lett; 2004 Aug; 366(1):97-102. PubMed ID: 15265598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach.
    Grupe M; Grunnet M; Bastlund JF; Jensen AA
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):187-200. PubMed ID: 25441336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Volatile organic compounds inhibit human and rat neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
    Bale AS; Meacham CA; Benignus VA; Bushnell PJ; Shafer TJ
    Toxicol Appl Pharmacol; 2005 May; 205(1):77-88. PubMed ID: 15885267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
    Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
    Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors.
    Grupe M; Jensen AA; Ahring PK; Christensen JK; Grunnet M
    Br J Pharmacol; 2013 Apr; 168(8):2000-10. PubMed ID: 23278456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.
    Chavez-Noriega LE; Crona JH; Washburn MS; Urrutia A; Elliott KJ; Johnson EC
    J Pharmacol Exp Ther; 1997 Jan; 280(1):346-56. PubMed ID: 8996215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes.
    Zwart R; Vijverberg HP
    Mol Pharmacol; 1998 Dec; 54(6):1124-31. PubMed ID: 9855643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium flux through predominantly independent purinergic ATP and nicotinic acetylcholine receptors.
    Rogers M; Colquhoun LM; Patrick JW; Dani JA
    J Neurophysiol; 1997 Mar; 77(3):1407-17. PubMed ID: 9084606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies.
    Pandya AA; Yakel JL
    Biochem Pharmacol; 2013 Oct; 86(8):1054-62. PubMed ID: 23732296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced inhibition of a mutant neuronal nicotinic acetylcholine receptor by agonists: protection of function by (E)-N-methyl-4-(3-pyridinyl)-3-butene-1-amine (TC-2403).
    Papke RL
    J Pharmacol Exp Ther; 2002 May; 301(2):765-73. PubMed ID: 11961083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.